找货集市
扫码去集市看看
买家服务
卖家服务
关于我们
7*24在线客服
客服
智能助手
AI助手
系统消息
消息
扫码进入小程序
小程序
搜索
快速询价
快速询价
收藏
欧盟重新评估赤藓糖醇作为食品添加剂的安全性
营养素制造网
2023-12-26
2
#原料快讯
内容摘要
食品伙伴网讯 2023年12月20日,据欧盟食品安全局(EFSA)消息,欧盟食品添加剂和调味剂小组(FAF)重新评估了赤藓糖醇(erythritol)(E 968)作为食品添加剂的安全性。部分原文报...

食品伙伴网讯  2023年12月20日,据欧盟食品安全局(EFSA)消息,欧盟食品添加剂和调味剂小组(FAF)重新评估了赤藓糖醇(erythritol)(E 968)作为食品添加剂的安全性。

部分原文报道如下:

This opinion addresses the re-evaluation of erythritol (E?968) as food additive and an application for its exemption from the laxative warning label requirement as established under Regulation (EU) No 1169/2011. Erythritol is a polyol obtained by fermentation with Moniliella pollinis BC or Moniliella megachiliensis KW3-6, followed by purifications and drying. Erythritol is readily and dose-dependently absorbed in humans and can be metabolised to erythronate to a small extent. Erythritol is then excreted unchanged in the urine. It does not raise concerns regarding genotoxicity. The dataset evaluated consisted of human interventional studies. The Panel considered that erythritol has the potential to cause diarrhoea in humans, which was considered adverse because its potential association with electrolyte and water imbalance. The lower bound of the range of no observed adverse effect levels (NOAELs) for diarrhoea of 0.5 g/kg body weight (bw) was identified as reference point. The Panel considered appropriate to set a numerical acceptable daily intake (ADI) at the level of the reference point. An ADI of 0.5 g/kg bw per day was considered by the Panel to be protective for the immediate laxative effect as well as potential chronic effects, secondary to diarrhoea. The highest mean and 95th percentile chronic exposure was in children (742 mg/kg bw per day) and adolescents (1532 mg/kg bw per day). Acute exposure was maximally 3531 mg/kg bw per meal for children at the 99th percentile. Overall, the Panel considered both dietary exposure assessments an overestimation. The Panel concluded that the exposure estimates for both acute and chronic dietary exposure to erythritol (E 968) were above the ADI, indicating that individuals with high intake may be at risk of experiencing adverse effects after single and repeated exposure. Concerning the new application, the Panel concluded that the available data do not support the proposal for exemption.